[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA952165B - Branched polyoxaalkyl macromolecules process for making them and their uses - Google Patents

Branched polyoxaalkyl macromolecules process for making them and their uses

Info

Publication number
ZA952165B
ZA952165B ZA952165A ZA952165A ZA952165B ZA 952165 B ZA952165 B ZA 952165B ZA 952165 A ZA952165 A ZA 952165A ZA 952165 A ZA952165 A ZA 952165A ZA 952165 B ZA952165 B ZA 952165B
Authority
ZA
South Africa
Prior art keywords
polyoxaalkyl
branched
macromolecules
making
nucleus
Prior art date
Application number
ZA952165A
Other languages
English (en)
Inventor
Luigia Gozzini
Monica Muttoni
Christoph De Haen
Original Assignee
Bracco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Spa filed Critical Bracco Spa
Publication of ZA952165B publication Critical patent/ZA952165B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/06—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules
    • A61K51/065—Macromolecular compounds, carriers being organic macromolecular compounds, i.e. organic oligomeric, polymeric, dendrimeric molecules conjugates with carriers being macromolecules
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyethers (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
ZA952165A 1994-03-18 1995-03-16 Branched polyoxaalkyl macromolecules process for making them and their uses ZA952165B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI940512A IT1270994B (it) 1994-03-18 1994-03-18 Macromolecole ramificate a struttura poliossialchilica e loro usi

Publications (1)

Publication Number Publication Date
ZA952165B true ZA952165B (en) 1995-12-14

Family

ID=11368259

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952165A ZA952165B (en) 1994-03-18 1995-03-16 Branched polyoxaalkyl macromolecules process for making them and their uses

Country Status (14)

Country Link
US (1) US5780644A (xx)
EP (1) EP0750649B1 (xx)
JP (1) JPH09510489A (xx)
KR (1) KR970701748A (xx)
AT (1) ATE211155T1 (xx)
AU (1) AU689244B2 (xx)
CA (1) CA2185647A1 (xx)
DE (1) DE69524738T2 (xx)
FI (1) FI963646A0 (xx)
IL (1) IL113004A (xx)
IT (1) IT1270994B (xx)
NO (1) NO312901B1 (xx)
WO (1) WO1995025763A1 (xx)
ZA (1) ZA952165B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019240A1 (en) * 1994-12-21 1996-06-27 Novartis Ag Oligonucleotide-dendrimer conjugates
IT1277414B1 (it) * 1995-08-02 1997-11-10 Bracco Spa Uso di macromolecole di tipo dendrimerico come catalizzatori o coadiuvanti delle reazioni in condizioni di trasferimento di fase
IT1277596B1 (it) * 1995-09-15 1997-11-11 Bracco Spa Composti macromolecolari di tipo dendrimerico
WO1997014740A1 (en) * 1995-10-19 1997-04-24 Receptagen Corporation Discrete-length polyethylene glycols
DE19624705A1 (de) * 1996-06-20 1998-01-08 Deutsches Krebsforsch Dendrimere auf Saccharid-Basis
US6214988B1 (en) 1999-01-03 2001-04-10 Schlumberger Technology Corporation Process for making an HMX product
US6201117B1 (en) 1999-05-26 2001-03-13 Schlumberger Technology Corporation Process for making a 1,3,5,7-tetraalkanoyl-1,3,5,7-tetraazacyclooctane
US6265573B1 (en) 1999-05-26 2001-07-24 Schlumberger Technology Corporation Purification process
US6428724B1 (en) 1999-05-26 2002-08-06 Schlumberger Technology Corporation Granulation process
US6194571B1 (en) 1999-05-26 2001-02-27 Schlumberger Technology Corporation HMX compositions and processes for their preparation
YU6502A (sh) 1999-07-29 2005-06-10 Epix Medical Inc. Usmeravanje multimernih agenasa za dobijanje kontrasta pri dijagnostičkom snimanju putem multilokusnog vezivanja
US7560520B1 (en) 2004-11-08 2009-07-14 The United States Of America As Represented By The Secretary Of The Army Interface-directed branched polymer transports and methods for producing same
US7645854B2 (en) * 2005-03-04 2010-01-12 Central Michigan University Board Of Trustees Conjugate addition products of primary amines and activated acceptors
EP1955712A1 (en) 2007-02-09 2008-08-13 Scil proteins GmbH Multimeric conjugate
US8178726B2 (en) 2007-03-15 2012-05-15 Huntsman Petrochemical Llc High functionality amine compounds and uses therefor
CN102834435B (zh) * 2010-03-30 2015-04-22 斯帕果图像有限公司 支化的紧凑型聚乙二醇衍生物
US8816099B2 (en) * 2010-03-31 2014-08-26 Nof Corporation Polyfunctional polyoxyalkylene compound, and producing method and intermediate thereof
US9133114B2 (en) * 2012-01-31 2015-09-15 University Of Maryland, Baltimore Dendrimers and methods of preparing same through proportionate branching

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737550A (en) * 1983-01-07 1988-04-12 The Dow Chemical Company Bridged dense star polymers
US4568737A (en) * 1983-01-07 1986-02-04 The Dow Chemical Company Dense star polymers and dendrimers
US5099042A (en) * 1989-03-14 1992-03-24 Thiokol Corporation Synthesis of tetrafunctional polyethers and compositions formed therefrom
US5041516A (en) * 1989-06-21 1991-08-20 Cornell Research Foundation, Inc. Dendritic molecules and method of production
US5294365A (en) * 1991-12-12 1994-03-15 Basf Corporation Hydroxypolyethers as low-foam surfactants

Also Published As

Publication number Publication date
IL113004A0 (en) 1995-06-29
ITMI940512A1 (it) 1995-09-18
ATE211155T1 (de) 2002-01-15
US5780644A (en) 1998-07-14
AU689244B2 (en) 1998-03-26
JPH09510489A (ja) 1997-10-21
FI963646A (fi) 1996-09-16
CA2185647A1 (en) 1995-09-28
IL113004A (en) 2000-08-31
IT1270994B (it) 1997-05-26
FI963646A0 (fi) 1996-09-16
NO963872L (no) 1996-09-16
WO1995025763A1 (en) 1995-09-28
NO963872D0 (no) 1996-09-16
AU2070395A (en) 1995-10-09
DE69524738D1 (de) 2002-01-31
NO312901B1 (no) 2002-07-15
KR970701748A (ko) 1997-04-12
DE69524738T2 (de) 2002-06-13
EP0750649A1 (en) 1997-01-02
ITMI940512A0 (it) 1994-03-18
EP0750649B1 (en) 2001-12-19

Similar Documents

Publication Publication Date Title
ZA952165B (en) Branched polyoxaalkyl macromolecules process for making them and their uses
PT1204824E (pt) Maquina de carrocel para o tratamento de corpos ocos, compreendendo um circuito aperfeicoado de distribuicao de pressao
DE69726378D1 (de) Gefärbte Photoresists sowie Methoden und Artikel, die diese umfassen
AU8154694A (en) Methods of increasing TGF-13 in the brain, inhibiting Alzeheimers disease and inhibiting B-amyloid peptide mediated neurotoxicity.
EP0871496A4 (xx)
EP1009440A4 (en) METHODS OF INHIBITING RESPONSES ASSOCIATED WITH IMMUNOSTIMULATOR DNA
DE69331903D1 (de) Veränderte Antikörper, damit zusammenhängende Produkte und Verfahren
DE69711640D1 (de) Naphthopyrane, zusammensetzungen und artikel die diese enthalten
BG101139A (en) Heteroatoms-containing cyclopentanopyridyloxazolidinons
DE69906938D1 (de) Glococorticoid selektive entzündungshemmende mittel
ZA976967B (en) Device and process for separating magnetic materials from pharmaceutical preparations, their starting or intermediate products, as well as agents that are produced with the of said device.
DE68912527D1 (de) Konditionierungsverfahren, Verpackungseinlage und Konditionierungskette.
DE69837984D1 (de) Gefärbte Fotolacke sowie Methoden und Artikel, die diese umfassen
DE59703693D1 (de) Pflanzenbehandlungsmittel
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
ES1030858Y (es) Maquina plantadora para hortalizas y similares.
MX9303843A (es) 4-iminoquinolinas, procedimiento para su preparacion y su empleo.
DE69915690D1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
HUP9903786A3 (en) 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d,methods for their production and pharmaceutical compositions thereof
MX9603516A (es) Derivados de oxima y su uso como pesticidas.
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
ATE183476T1 (de) Aufteileinrichtung
GB9726897D0 (en) Process
ZA9810759B (en) Proliferatively active product for treating proliferating cells.
ES1030885Y (es) Dispositivo luminoso para piezas de joyeria y bisuteria.